Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Clinical Biochemistry
|
July 6, 2004
S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma
Riikka Harpio, Roland Einarsson
Clinical Biochemistry
|
July 6, 2004
Clinical utility of cytokeratins as tumor markers
Vivian Barak, Helena Goike, Katja W Panaretakis, et al.
Clinical Chemistry
|
July 13, 2004
Sensitive nonradiometric method for determining thymidine kinase 1 activity
Anders Ohrvik, Maria Lindh, Roland Einarsson, et al.
Anticancer Research
|
July 5, 2020
Non-invasive Detection of Bladder Cancer by UBC Rapid Test, Ultrasonography and Cytology
Vivian Barak, Dror Itzkovich, Roland Einarsson, et al.
Journal of Veterinary Internal Medicine
|
November 2, 2004
Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease
Henrik von Euler, Roland Einarsson, Ulf Olsson, et al.
Cancer
|
October 31, 2002
Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma
Paweł Sedlaczek, Irena Frydecka, Marian Gabryś, et al.
Anesthesia and Analgesia
|
November 10, 2009
The brain is a source of S100B increase during endotoxemia in the pig
Miklos Lipcsey, Matts Olovsson, Erik Larsson, et al.
Scandinavian Journal of Urology
|
April 20, 2017
Evaluation of the diagnostic accuracy of UBC<sup>®</sup> Rapid in bladder cancer: a Swedish multicentre study
Johan Styrke, Helene Henriksson, Börje Ljungberg, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 29, 2005
Tumor markers in breast cancer- European Group on Tumor Markers recommendations
Rafael Molina, Vivian Barak, Arie van Dalen, et al.
Melanoma Research
|
November 18, 2008
Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma
Asa Bolander, Margrét Agnarsdóttir, Gunnar Wagenius, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Clinical Biochemistry
|
July 6, 2004
S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma
Riikka Harpio, Roland Einarsson
Clinical Biochemistry
|
July 6, 2004
Clinical utility of cytokeratins as tumor markers
Vivian Barak, Helena Goike, Katja W Panaretakis, et al.
Clinical Chemistry
|
July 13, 2004
Sensitive nonradiometric method for determining thymidine kinase 1 activity
Anders Ohrvik, Maria Lindh, Roland Einarsson, et al.
Anticancer Research
|
July 5, 2020
Non-invasive Detection of Bladder Cancer by UBC Rapid Test, Ultrasonography and Cytology
Vivian Barak, Dror Itzkovich, Roland Einarsson, et al.
Journal of Veterinary Internal Medicine
|
November 2, 2004
Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease
Henrik von Euler, Roland Einarsson, Ulf Olsson, et al.
Cancer
|
October 31, 2002
Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma
Paweł Sedlaczek, Irena Frydecka, Marian Gabryś, et al.
Anesthesia and Analgesia
|
November 10, 2009
The brain is a source of S100B increase during endotoxemia in the pig
Miklos Lipcsey, Matts Olovsson, Erik Larsson, et al.
Scandinavian Journal of Urology
|
April 20, 2017
Evaluation of the diagnostic accuracy of UBC<sup>®</sup> Rapid in bladder cancer: a Swedish multicentre study
Johan Styrke, Helene Henriksson, Börje Ljungberg, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 29, 2005
Tumor markers in breast cancer- European Group on Tumor Markers recommendations
Rafael Molina, Vivian Barak, Arie van Dalen, et al.
Melanoma Research
|
November 18, 2008
Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma
Asa Bolander, Margrét Agnarsdóttir, Gunnar Wagenius, et al.
Page
of 2